文献速递细菌感染、耐药与抗菌药物医院感染防控新发突发、热带与寄生虫病

亚洲监测网络ACORN-HAI:严重医疗相关感染与抗菌药物耐药的多中心前瞻性队列研究

Severe health-care-associated infections and antimicrobial resistance in an Asian Surveillance Network (ACORN-HAI): a multicentre, prospective cohort study.
PubMed 文献 · Lancet Infect Dis · 2026-08-21

该多中心前瞻性队列研究在19个亚洲国家和地区41家医院连续纳入9496例 microbiologically 确诊的呼吸机相关肺炎或血流感染患者,分析抗菌药物耐药(AMR)流行病学与疾病负担。

核心结论

  • AMR细菌血流感染和VAP在亚洲常见,与高死亡率和生活质量下降相关,尤其CRA和CRE感染及儿童和年轻成人。

研究设计与样本

  • 大规模前瞻性多国多中心队列研究,2022年9月1日至2025年2月28日在19个亚洲国家和地区41家医院连续纳入任何年龄患者。

临床怎么用

  • 应关注VAP、儿童和年轻成人及下中等收入国家中AMR归因死亡高风险。
  • CRA和CRE感染需优化抗菌治疗方案,避免广泛使用次优方案。
  • 亟需公平获取有效治疗和情境特异性证据以指导抗菌药物管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antimicrobial resistance (AMR) poses a major global health threat, with health-care-associated infections contributing substantially to mortality. Attributable disease burden remains poorly quantified by relying on cross-sectional and microbiology data. We aimed to characterise AMR epidemiology and disease burden associated with ventilator-associated pneumonia and bloodstream infection in a network of hospitals in Asia. METHODS: This large-scale, prospective, multinational, multicentre cohort study consecutively enrolled patients of any age with microbiologically-confirmed ventilator-associated pneumonia, hospital-acquired bloodstream infections, or health-care-associated bloodstream infections from 41 selected hospitals capable of standardised prospective data collection in 19 Asian countries and regions. Patients with pathogens typically associated with community-acquired infection or not recognised causes of health-care-associated infection were excluded according to predefined protocol criteria, and patients were followed for 28 days. The primary outcome was 28-day mortality from infection onset. Pathogen profiles, antimicrobial prescriptions, attributable mortality, and health-related quality-of-life outcomes were analysed. FINDINGS: Between Sept 1, 2022, and Feb 28, 2025, 10 111 patients were enrolled, and after exclusions, 9496 patients were included in the final analysis. 9642 infection episodes were analysed, comprising 6597 (68·4%) bloodstream infections and 3045 (31·6%) ventilator-associated pneumonia. Of these infections, 7102 (73·7%) of 9642 infection episodes were associated with AMR bacteria, and Gram-negative bacteria were predominant (7599 [78·8%]). Crude 28-day mortality was 2674 (37·7%) of 7102 AMR infection episodes and 1900 (40·6%) of 4683 multidrug resistance infection episodes, with the highest for carbapenem-resistant Acinetobacter spp (CRA; 51·3%) and carbapenem-resistant Enterobacterales (CRE; 48·4%). AMR-attributable mortality was the highest in ventilator-associated pneumonia (16·9%, 95% CI 13·0-20·9), individuals aged 5-14 years (11·7%, 95% CI 1·6-21·8), individuals aged 15-49 years (11·2%, 95% CI 7·2-15·2), and lower-middle-income countries (10·7%, 95% CI 7·0-14·4). By pathogens, CRA and CRE had the highest attributable mortality (19·4%, 95% CI 14·1-24·7 vs 16·2%, 95% CI 12·8-19·6) and also had the poorest quality-of-life outcomes. Most carbapenem-resistant Gram-negative infections were treated with carbapenems (57·8%) or polymyxins (35·6%). INTERPRETATION: AMR bacterial bloodstream infections and ventilator-associated pneumonia were common and associated with high mortality and reduced quality of life in Asia, particularly in infections due to carbapenem-resistant Acinetobacter spp and CRE, and among children and younger adults. The widespread use of suboptimal antimicrobial regimens highlights the urgent need for equitable access to effective therapies and context-specific evidence to guide antimicrobial stewardship. FUNDING: Wellcome Trust, National University of Singapore, Yong Loo Lin School of Medicine, Duke-NUS Medical School, Nanyang Technological University (Lee Kong Chian School of Medicine), Singapore National Centre for Infectious Diseases, and Singapore Medical Research Council.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Mo Y, Hao X, Ding Y, et al. Severe health-care-associated infections and antimicrobial resistance in an Asian Surveillance Network (ACORN-HAI): a multicentre, prospective cohort study. Lancet Infect Dis. 2026. PMID: 42628558. doi:10.1016/S1473-3099(26)00357-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。